INDIANAPOLIS , May 19, 2021 /PRNewswire/ -- New data from across Eli Lilly and Company's (NYSE: LLY) oncology portfolio will be presented at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting, held June 4-8, 2021 . The data include new analyses of Verzenio ® (abemaciclib) from the
investor.lilly.com
investor.lilly.com
Create attached notes ...
